Known targets — ChEMBL curated mechanism
GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ
The experimentally established mechanism targets of Brexanolone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 known ✓ | P14867 | 3/20 | 1.00 |
| ▸ | GABRG2 known ✓ | P18507 | 3/20 | 1.00 |
| ▸ | GABRB3 known ✓ | P28472 | 3/20 | 1.00 |
| ▸ | GABRA2 known ✓ | P47869 | 3/20 | 1.00 |
| ▸ | GABRB2 known ✓ | P47870 | 3/20 | 1.00 |
| ▸ | GABRP known ✓ | O00591 | 2/20 | 1.00 |
| ▸ | GABRD known ✓ | O14764 | 2/20 | 1.00 |
| ▸ | GABRB1 known ✓ | P18505 | 2/20 | 1.00 |
| ▸ | GABRA5 known ✓ | P31644 | 2/20 | 1.00 |
| ▸ | GABRA3 known ✓ | P34903 | 2/20 | 1.00 |
| ▸ | GABRA4 known ✓ | P48169 | 2/20 | 1.00 |
| ▸ | GABRE known ✓ | P78334 | 2/20 | 1.00 |
| ▸ | GABRA6 known ✓ | Q16445 | 2/20 | 1.00 |
| ▸ | GABRG1 known ✓ | Q8N1C3 | 2/20 | 1.00 |
| ▸ | GABRG3 known ✓ | Q99928 | 2/20 | 1.00 |
| ▸ | GABRQ known ✓ | Q9UN88 | 2/20 | 1.00 |
| ▸ | G6PD | P11413 | 7/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 5/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Brexanolone SCHEMBL23743678 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP2C9GABRA1GABRG2 | |
| Brexanolone SCHEMBL25079438 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP2C9GABRA1GABRG2 | |
| Brexanolone SCHEMBL23699798 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP2C9GABRA1GABRG2 | |
| Brexanolone SCHEMBL23743691 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP2C9GABRA1GABRG2 | |
| Brexanolone SCHEMBL23743739 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP2C9GABRA1GABRG2 | |
| Brexanolone SCHEMBL24450442 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP2C9GABRA1GABRG2 | |
| Brexanolone SCHEMBL23743720 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP2C9GABRA1GABRG2 | |
| Brexanolone SCHEMBL24285706 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP2C9GABRA1GABRG2 | |
| Brexanolone SCHEMBL25079445 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP2C9GABRA1GABRG2 | |
| Brexanolone SCHEMBL22451790 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP2C9GABRA1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542296-B2 | Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2023-01-03 | — | — | US | disclosed |
| US-20210238220-A1 | NEUROSTEROID COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238220-A1 | NEUROSTEROID COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS | CYP11B2, CYP21A2, CYP11B1 | GABRA1 444/4885GABRG2 470/4885GABRB3 285/4885 |
| US-11542296-B2 | Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders | CYP11B2, CYP21A2, CYP11B1 | GABRA1 444/4885GABRG2 470/4885GABRB3 285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.